aTyr Pharma, Inc. - Common Stock (NQ:ATYR)

0.2872 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about aTyr Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs ↗

September 20, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Top 3 Health Care Stocks That May Explode In September ↗

September 19, 2025

Via Benzinga

Why Is aTyr Stock Falling Today? ↗

September 15, 2025

Via Stocktwits

Goldman Sachs To Rally around 9%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 16, 2025

Via Benzinga

Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September ↗

September 15, 2025

Via Benzinga

Which stocks are most active on Monday? ↗

September 15, 2025

Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 15, 2025

Via Benzinga

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR

September 15, 2025

From DJS Law Group

Via Business Wire

ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results ↗

September 15, 2025

ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates.

Via Benzinga

Nasdaq Gains Over 100 Points; Tesla Shares Spike Higher ↗

September 15, 2025

Via Benzinga

New Mountain Finance, Texas Instruments, Analog Devices And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 15, 2025

Via Benzinga

Why Check-Cap Shares Are Trading Higher By 183%; Here Are 20 Stocks Moving Premarket ↗

September 15, 2025

Via Benzinga

Why Is Atyr Pharma Stock Slipping Premarket? ↗

September 15, 2025

Investors braced for imminent Phase 3 EFZO-FIT trial results of efzofitimod, with analysts calling it a key inflection point.

Via Stocktwits

1 Small-Cap Biotech Stock Poised for a Breakout ↗

September 11, 2025

The next couple of weeks could reveal a great deal about this stock's prospects.

Via The Motley Fool

Nvidia To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 22, 2025

Via Benzinga

Alerus Financial Posts Better-Than-Expected Earnings, Joins Celcuity, SES AI, Abercrombie & Fitch And Other Big Stocks Moving Higher On Monday ↗

July 28, 2025

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 23, 2025

Via Benzinga

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday ↗

July 23, 2025

Via Benzinga

These stocks are gapping in today's session ↗

July 23, 2025

The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

5 Biotech Stocks with Highly Anticipated Pending Results ↗

June 26, 2025

Via Stocktwits

Topics Intellectual Property

These stocks that are showing activity before the opening bell on Friday. ↗

April 25, 2025

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 25, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

April 08, 2025

As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

What's going on in today's after hours session ↗

March 13, 2025

As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update

March 13, 2025

From aTyr Pharma, Inc.

Via GlobeNewswire

Earnings Scheduled For March 13, 2025 ↗

March 13, 2025

Via Benzinga

Which stocks are gapping on Friday? ↗

March 07, 2025

In today's session, there are notable price gaps in the US markets on Friday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

March 06, 2025

No safety concerns identified by independent data and safety monitoring board (DSMB), which recommends continuation of study without any modifications.

From aTyr Pharma, Inc.

Via GlobeNewswire

aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results

March 04, 2025

Management to host conference call and webcast on March 13th at 5:00 pm EDT / 2:00 pm PDT

From aTyr Pharma, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.